Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04264234
Other study ID # 18-9.1/27
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 13, 2018
Est. completion date February 1, 2020

Study information

Verified date March 2022
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.


Recruitment information / eligibility

Status Completed
Enrollment 98
Est. completion date February 1, 2020
Est. primary completion date February 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Monitoring of placenta previa - To apply before the 28th week - To have a low-risk second trimester screening test - No malformation detected in the anomaly screening Exclusion Criteria: - Multiple pregnancies - Pregnancy complicated with preeclampsia - Pregnancy complicated by gestational hypertension - Pregnancy complicated by gestational diabetes mellitus

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Vaginal Ultrasonography
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.
Magnetic Resonance Imaging
Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.

Locations

Country Name City State
Turkey Ege University Hospital Izmir

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The number of placental invasion pathologies Placental invasion pathologies detected during delivery will be evaluated. 1 day
Primary The number of preterm birth The relation between preterm birth and placental invasion pathologies will be assessed. 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT04518163 - Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa N/A
Recruiting NCT04518150 - Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section N/A
Recruiting NCT03638024 - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Terminated NCT01996345 - Vaginal Pessary Versus Expectant Management for Placenta Previa N/A
Recruiting NCT04609527 - Management of Placenta Accreta Spectrum Phase 2/Phase 3
Completed NCT03431116 - Low Implanted Second Trimester Placenta and Placenta Previa N/A
Completed NCT03321435 - The Placenta Previa and Fetal Weight N/A
Enrolling by invitation NCT05529381 - Anxiety and Depressive Symptoms in Placenta Previa / Accreta
Completed NCT05340205 - Blood Loss During Cesarean Delivery in Placenta Previa Patients Phase 4
Completed NCT03570723 - Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa N/A
Completed NCT05283122 - Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases N/A
Withdrawn NCT01442207 - Cerclage for Prevention on Preterm Birth in Women With Placenta Previa Phase 3
Not yet recruiting NCT03451136 - Cervical Length in Cases of Placenta Previa N/A
Completed NCT02966197 - Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta N/A
Recruiting NCT02590484 - The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta N/A
Recruiting NCT05802251 - Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
Completed NCT03542552 - Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa Phase 3
Recruiting NCT03124472 - Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa N/A
Recruiting NCT03633175 - Progesterone in Patients With Placenta Previa Phase 2
Not yet recruiting NCT03208842 - Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar N/A